Southern Research to Target Bio-Threats under new BARDA Contract

The Biomedical Advanced Research and Development Authority (BARDA) has awarded Southern Research two contracts for nonclinical research services advancing the agency’s work to protect the U.S. against infectious disease and bio-terror threats. One of the contracts is for developing novel animal models to test the effectiveness of medical countermeasures against biological threat agents. The BARDA contracts have a minimum value of $45 million and a maximum value of $90 million and a base term of five years. “This work positions Southern Research to play a key role in protecting against potentially serious public health issues,” said Tim McGrath, vice president, Drug Development. “We have the expertise and capabilities to accelerate the development of vaccines and therapeutics that are effective against biological threat agents.”

Our Current Sponsors